Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions

Oncogene

Volumn 17, Issue 18, 1998, Pages 2383-2392

  Floettmann, J Eike ^a   Eliopoulos, Aristides G ^b   Jones, Matthew ^a   Young, Lawrence S ^b   Rowe, Martin ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

CD40; CD54; Epstein Barr virus; LMP 1; NF B; TNF R

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OLIGOMER; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LATENT VIRUS INFECTION; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; SIGNAL TRANSDUCTION;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0032487999     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202144     Document Type: Article

References (46)

1. Arenzana-Seisdedos F, Fernandez B, Dominguez I, Jacque JM, Thomas D, Diaz-Meco MT, Moscat J and Virelizier JL. (1993). J. Virol., 67, 6596-6604.
2. Baichwal VR and Sugden B. (1988). Oncogene, 2, 461-467.
3. Boucher LM, Marengere LEM, Lu Y, Thukral S and Mak TW. (1997). Biochem. Biophys. Res. Commun., 233, 592-600.
4. Brattsand G, Cantrell DA, Ward S, Ivars F and Gullberg M. (1990). J. Immunol., 144, 3651-3658.
5. Brodeur SR, Cheng G, Baltimore D and Thorley-Lawson DA, T-L. (1997). J. Biol. Chem., 272, 19777-19784.
6. Dawson C, Rickinson AB and Young LS. (1990). Nature, 344, 777-780.
7. Devergne O, Hatzivassiliou E, Izumu KM, Kaye KM, Kleijnen MF, Kieff E and Mosialos G. (1996). Mol. Cell. Biol., 16, 7098-7108.
8. Eliopoulos A, Stack M, Dawson C, Kaye K, Rowe M and Young L. (1997). Oncogene, 14, 2899-2916.
9. Eliopoulos A and Young LS. (1998). Oncogene, 16, 1725-1736.
10. Floettmann JE and Rowe M. (1997). Oncogene, 15, 1851-1858.
11. Floettmann JE, Ward K, Rickinson AB and Rowe M. (1996). Virology, 223, 29-40.
12. Franken M, Devergne O, Rosenzweig M, Annis B, Kieff E and Wang F. (1996). J. Virol., 70, 7819-7826.
13. Fries KL, Miller WE and Raab-Traub N. (1996). J. Virol., 70, 8653-8659.
14. Gires O, Zimber-Strobl U, Gonella R, Ueffing M, Marschall G, Zeidler R, Pich D and Hammerschmidt W. (1997). EMBO J., 16, 6131-6140.
15. Hammarskjöld M-L and Simurda MC. (1992). J. Virol., 66, 6496-6501.
16. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E and Rickinson A. (1991). Cell, 65, 1107-1115.
17. Henriquez N, Floettmann E, Salmon M, Rowe M and Rickinson AB. (1998). (Submitted for publication).
18. Herrero JA, Mathew P and Paya CV. (1995). J. Virol., 69, 2168-2174.
19. Huen DS, Henderson SA, Croom-Carter D and Rowe M. (1995). Oncogene, 10, 549-560.
20. Ishida T, Tojo T, Aoki T, Kobayashi N, Ohishi T, Watanabe T, Yamamoto T and Inoue J. ( 1996). Proc. Natl. Acad. Sci. USA, 93, 9437-9442.
21. Izumi KM and Kieff ED. (1997). Proc. Natl. Acad. Sci. USA. 94, 12592-12597.
22. Jefferies WA, Green JR and Williams AF. (1985). J. Exp. Med., 162, 117-127.
23. Kaye KM, Izumi KM and Kieff E. (1993). Proc. Natl. Acad. Sci. USA, 90, 9150-9154.
24. Kieff E. (1996). Fields Virology, Vol. 2. Fields BN, Knipe DM and Howley PM (eds). Lippincott-Raven Publishers: Philadelphia, pp. 2343-2396.
25. Kieser A, Kilger E, Gires O, Ueffing M, Kolch W and Hammerschmidt W. (1997). EMBO J., 16, 6478-6485.
26. Kilger E, Kieser A, Baumann M and Hammerschmidt W. (1998). EMBO J., 17, 1700-1709.
27. Laherty CD, Hu HM, Opipari AW, Wang F and Dixit VM. (1992). J. Biol. Chem., 267, 24157-24160.
28. Ledebur HC and Parks TP. (1995). J. Biol. Chem., 270, 933-943.
29. Mitchell T and Sugden B. (1995). J. Virol., 69, 2968-2976.
30. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C and Kieff E. (1995). Cell, 80, 389-399.
31. Paine E, Scheinman AS, Baldwin Jr, AS and Raab-Traub N. (1995). J. Virol., 69, 4572-4576.
32. Peng M and Lundgren E. (1992). Oncogene, 7, 1775-1782.
33. Pilon M, Gullberg M and Lundgren E. (1991). J. Immunol., 146, 1047-1051.
34. Reinhard C, Shamoon B, Shyamala V and Williams FT. (1997). EMBO J., 16, 1080-1092.
35. Rickinson AB and Kieff E. (1996). Fields Virology, Vol. 2. Fields BN, Knipe DM and Howley PM. (eds). Lippincott-Raven Publishers: Philadelphia, pp. 2397-2446.
36. Roberts MF and Cooper NR. (1998). Virology, 240, 93-99.
37. Rothe M, Sarma V, Dixit VM and Goeddel DV. (1995). Science, 269, 1424-1427.
38. Rowe M, Evans HS, Young LS, Hennessy K, Kieff E and Rickinson A. (1987). J. Gen. Virol., 68, 1575-1586.
39. Rowe M, Lear A, Croom-Carter D, Davies AH and Rickinson AB. (1992). J. Virol., 66, 122-131.
40. Rowe M, Peng-Pilon M, Huen DS, Hardy R, Croom-Carter D, Lundgren E and Rickinson AB. (1994). J. Virol., 68, 5602-5612.
41. Sandberg M, Hammerschmidt W and Sugden B. (1997). J. Virol., 71, 4649-4656.
42. van Konten C and Banchereau J. (1997). Curr. Opin. Immunology, 9, 330-337.
43. Wang D, Liebowitz D and Kieff D. (1985). J. Virol., 43, 831-840.
44. Wang D, Liebowitz D, Wang F, Gregory C, Rickinson A, Larson R, Springer T and Kieff E. (1988). J. Virol., 62, 4173-4184.
45. Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A and Kieff E. (1990). J. Virol., 64, 2309-2318.
46. Zimber-Strobl U, Kempkes B, Marschall G, Zeidler R, van Kooten C, Banchereau J, Bornkamm GW and Hammerschmidt, W. (1996). EMBO J., 15, 7070-7078.